首页 > 市场调查报告书 > 製药

医药品法规环境

市场调查报告书

商品编码

1541272

2024-2032 年按类型、产品、最终用户和地区分類的上市后药物警戒和医疗资讯市场报告

Post-marketing Pharmacovigilance and Medical Information Market Report by Type, Product, End User, and Region 2024-2032

出版日期: 2024年08月10日 | 出版商:

IMARC | 英文 136 Pages | 商品交期: 2-3个工作天内

价格

简介目录图表

2023年全球上市后药物警戒与医疗资讯IMARC Group规模达56亿美元。

上市后药物警戒和医疗资讯是在药品和医疗器材上市后监测其安全性和有效性的做法。它包括收集、监测和预防新药物、设备和疗法的不良反应。它透过澄清与益处有关的风险并反驳错误的指示，帮助保护患者免受不必要的伤害。除此之外，它还可以帮助研究人员确定整个药物配方週期所需的行动。因此，上市后药物警戒和医疗资讯在医疗保健行业中发挥重要作用，可评估患者和医疗专业人员之间传递的讯息的准确性。研究组织也使用它来规范药物安全指南。

上市后药物警戒与医疗资讯市场趋势：

全球老年人口的不断增长以及糖尿病、高血压、失智症、心血管疾病和骨质疏鬆症等各种慢性疾病的发生率不断上升，是增加药品消费的关键因素之一。此外，生活方式、呼吸道和心血管感染以及神经系统和肿瘤疾病日益频繁，导致全球药品销售量不断增加。这反过来又创造了积极的市场前景。与此一致的是，药物不良反应 (ADR) 的发生率不断上升，加上先进的 ADR 报告工具的采用，正在支持市场的成长。除此之外，医院、诊所、实验室和医学研究中心的扩张正在刺激全球对药物和医疗设备的需求。此外，各国政府正在实施多项措施来改善医疗基础设施和药物警戒服务并维护医疗资料库，这正在加强市场成长。此外，领先的市场参与者正专注于外包药物警戒业务（PVO）并引入基于云端的医疗资讯系统，以实现最佳准确性、成本效率、风险缓解、领域、改进的时间表和组织敏捷性，预计这将推动市场发展。

本报告回答的关键问题

全球上市后药物警戒和医疗资讯市场有多大？ 2024-2032年全球上市后药物警戒与医疗资讯市场的预期成长率为何？
推动全球上市后药物警戒和医疗资讯市场的关键因素是什么？
COVID-19 对全球上市后药物警戒与医疗资讯市场有何影响？
全球上市后药物警戒和医疗资讯市场按类型划分是怎样的？
基于最终用户的全球上市后药物警戒和医疗资讯市场的细分情况如何？
全球上市后药物警戒和医疗资讯市场的关键区域有哪些？
全球上市后药物警戒和医疗资讯市场的主要参与者/公司有哪些？

北美洲
- 美国
- 加拿大
亚太
- 中国
- 日本
- 印度
- 韩国
- 澳洲
- 印尼
- 其他的
欧洲
- 德国
- 法国
- 英国
- 义大利
- 西班牙
- 俄罗斯
- 其他的
拉丁美洲
- 巴西
- 墨西哥
- 其他的
中东和非洲
- 市场趋势
- 市场细分：按国家/地区
- 市场预测

第 10 章：SWOT 分析

概述
优势
弱点
机会
威胁

第 11 章：价值链分析

第 12 章：波特五力分析

概述
买家的议价能力
供应商的议价能力
竞争程度
新进入者的威胁
替代品的威胁

第 13 章：价格分析

第14章：竞争格局

市场结构
关键参与者
关键参与者简介
- Accenture Plc.
- ArisGlobal
- Cognizant Technology Solutions Corporation
- Ergomed Plc
- F. Hoffmann-La Roche Ltd.
- Icon Plc
- Parexel International Corporation
- Pharmaceutical Product Development, Inc.
- Wipro Ltd.

简介目录图表

Product Code: SR112024A6454

The global post-marketing pharmacovigilance and medical information market size reached US$ 5.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 13.0 Billion by 2032, exhibiting a growth rate (CAGR) of 9.52% during 2024-2032.

Post-marketing pharmacovigilance and medical information is the practice of monitoring the safety and efficacy of drugs and medical devices after their launch. It includes collection, surveillance, and prevention of adverse effects of new medicines, equipment, and therapies. It helps protect patients from unnecessary harm by clarifying risks concerning benefits and refuting false indications. Besides this, it assists researchers in determining required actions throughout the drug formulation cycle. As a result, post-marketing pharmacovigilance and medical information finds a considerable role in the healthcare industry to assess the accuracy of the delivered information between patients and medical professionals. It is also used in research organizations for regulating drug safety guidelines.

Post-marketing Pharmacovigilance and Medical Information Market Trends:

The growing global geriatric population and the rising occurrence of various chronic medical disorders, such as diabetes, hypertension, dementia, cardiovascular diseases, and osteoporosis, represent one of the key factors increasing the consumption of medicines. In addition, the increasing frequency of lifestyle, respiratory and cardiovascular infections, and neurological and oncological diseases are resulting in the increasing sales of drugs worldwide. This, in turn, is creating a positive market outlook. In line with this, the rising prevalence of Adverse Drug Reactions (ADRs), coupled with the incorporation of advanced ADR reporting tools, is supporting the market growth. Apart from this, the expansion of hospitals, clinics, laboratories, and medical research centers is catalyzing the demand for medications and medical devices across the globe. Moreover, governments of various countries are implementing several initiatives to improve healthcare infrastructure and pharmacovigilance services and maintain medical databases, which is strengthening the market growth. Furthermore, leading market players are focusing on outsourcing pharmacovigilance operations (PVO) and introducing cloud-based medical information systems for optimal accuracy, cost efficiency, risk mitigation, domain, improved timelines, and organizational agility, which is anticipated to drive the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global post-marketing pharmacovigilance and medical information market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, product and end user.

Breakup by Type:

Spontaneous Reporting

Intensified ADR Reporting

Targeted Spontaneous Reporting

Cohort Event Monitoring

EHR Mining

Breakup by Product:

Books

Online Media

Journals

Breakup by End User:

Hospitals

Research Organization

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Accenture Plc., ArisGlobal, Cognizant Technology Solutions Corporation, Ergomed Plc, F. Hoffmann-La Roche Ltd., Icon Plc, Parexel International Corporation, Pharmaceutical Product Development, Inc. and Wipro Ltd.

Key Questions Answered in This Report

1. How big is the global post-marketing pharmacovigilance and medical information market?
2. What is the expected growth rate of the global post-marketing pharmacovigilance and medical information market during 2024-2032?
3. What are the key factors driving the global post-marketing pharmacovigilance and medical information market?
4. What has been the impact of COVID-19 on the global post-marketing pharmacovigilance and medical information market?
5. What is the breakup of the global post-marketing pharmacovigilance and medical information market based on the type?
6. What is the breakup of the global post-marketing pharmacovigilance and medical information market based on the end user?
7. What are the key regions in the global post-marketing pharmacovigilance and medical information market?
8. Who are the key players/companies in the global post-marketing pharmacovigilance and medical information market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Post-marketing Pharmacovigilance and Medical Information Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Type

6.1 Spontaneous Reporting
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Intensified ADR Reporting
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Targeted Spontaneous Reporting
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 Cohort Event Monitoring
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
6.5 EHR Mining
- 6.5.1 Market Trends
- 6.5.2 Market Forecast

7 Market Breakup by Product

7.1 Books
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Online Media
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Journals
- 7.3.1 Market Trends
- 7.3.2 Market Forecast

8 Market Breakup by End User

8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Research Organization
- 8.2.1 Market Trends
- 8.2.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Asia-Pacific
- 9.2.1 China
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 Japan
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 India
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 South Korea
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Australia
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Europe
- 9.3.1 Germany
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 France
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Italy
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Spain
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Russia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Others
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 Accenture Plc.
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
  - 14.3.1.3 Financials
  - 14.3.1.4 SWOT Analysis
- 14.3.2 ArisGlobal
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
- 14.3.3 Cognizant Technology Solutions Corporation
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
  - 14.3.3.3 Financials
  - 14.3.3.4 SWOT Analysis
- 14.3.4 Ergomed Plc
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
  - 14.3.4.3 Financials
- 14.3.5 F. Hoffmann-La Roche Ltd.
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
  - 14.3.5.3 SWOT Analysis
- 14.3.6 Icon Plc
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
  - 14.3.6.3 Financials
  - 14.3.6.4 SWOT Analysis
- 14.3.7 Parexel International Corporation
  - 14.3.7.1 Company Overview
  - 14.3.7.2 Product Portfolio
  - 14.3.7.3 SWOT Analysis
- 14.3.8 Pharmaceutical Product Development, Inc.
  - 14.3.8.1 Company Overview
  - 14.3.8.2 Product Portfolio
  - 14.3.8.3 SWOT Analysis
- 14.3.9 Wipro Ltd.
  - 14.3.9.1 Company Overview
  - 14.3.9.2 Product Portfolio
  - 14.3.9.3 Financials

简介目录图表

List of Figures

Figure 1: Global: Post-marketing Pharmacovigilance and Medical Information Market: Major Drivers and Challenges
Figure 2: Global: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Post-marketing Pharmacovigilance and Medical Information Market: Breakup by Type (in %), 2023
Figure 5: Global: Post-marketing Pharmacovigilance and Medical Information Market: Breakup by Product (in %), 2023
Figure 6: Global: Post-marketing Pharmacovigilance and Medical Information Market: Breakup by End User (in %), 2023
Figure 7: Global: Post-marketing Pharmacovigilance and Medical Information Market: Breakup by Region (in %), 2023
Figure 8: Global: Post-marketing Pharmacovigilance and Medical Information (Spontaneous Reporting) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Post-marketing Pharmacovigilance and Medical Information (Spontaneous Reporting) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Post-marketing Pharmacovigilance and Medical Information (Intensified ADR Reporting) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Post-marketing Pharmacovigilance and Medical Information (Intensified ADR Reporting) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Post-marketing Pharmacovigilance and Medical Information (Targeted Spontaneous Reporting) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Post-marketing Pharmacovigilance and Medical Information (Targeted Spontaneous Reporting) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Post-marketing Pharmacovigilance and Medical Information (Cohort Event Monitoring) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Post-marketing Pharmacovigilance and Medical Information (Cohort Event Monitoring) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Post-marketing Pharmacovigilance and Medical Information (EHR Mining) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Post-marketing Pharmacovigilance and Medical Information (EHR Mining) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Post-marketing Pharmacovigilance and Medical Information (Books) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Post-marketing Pharmacovigilance and Medical Information (Books) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Post-marketing Pharmacovigilance and Medical Information (Online Media) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Post-marketing Pharmacovigilance and Medical Information (Online Media) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Post-marketing Pharmacovigilance and Medical Information (Journals) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Post-marketing Pharmacovigilance and Medical Information (Journals) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Post-marketing Pharmacovigilance and Medical Information (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Post-marketing Pharmacovigilance and Medical Information (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Post-marketing Pharmacovigilance and Medical Information (Research Organization) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Post-marketing Pharmacovigilance and Medical Information (Research Organization) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: North America: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: North America: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: United States: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: United States: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Canada: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Canada: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: Asia-Pacific: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: Asia-Pacific: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: China: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: China: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: Japan: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: Japan: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: India: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: India: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: South Korea: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: South Korea: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Australia: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Australia: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Indonesia: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Indonesia: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Others: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Others: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Europe: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Europe: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: Germany: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: Germany: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: France: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: France: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: United Kingdom: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: United Kingdom: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Italy: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Italy: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Spain: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Spain: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Russia: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Russia: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Others: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Others: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Latin America: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Latin America: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Brazil: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Brazil: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Mexico: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Mexico: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Others: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Others: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Middle East and Africa: Post-marketing Pharmacovigilance and Medical Information Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Middle East and Africa: Post-marketing Pharmacovigilance and Medical Information Market: Breakup by Country (in %), 2023
Figure 76: Middle East and Africa: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Global: Post-marketing Pharmacovigilance and Medical Information Industry: SWOT Analysis
Figure 78: Global: Post-marketing Pharmacovigilance and Medical Information Industry: Value Chain Analysis
Figure 79: Global: Post-marketing Pharmacovigilance and Medical Information Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Post-marketing Pharmacovigilance and Medical Information Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Breakup by Type (in Million US$), 2024-2032
Table 3: Global: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Breakup by Product (in Million US$), 2024-2032
Table 4: Global: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 5: Global: Post-marketing Pharmacovigilance and Medical Information Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Post-marketing Pharmacovigilance and Medical Information Market: Competitive Structure
Table 7: Global: Post-marketing Pharmacovigilance and Medical Information Market: Key Players

02-2729-4219

+886-2-2729-4219